OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
Karine Lacombe, Thomas Hueso, Raphaël Porcher, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000427-e000427
Open Access | Times Cited: 15
Karine Lacombe, Thomas Hueso, Raphaël Porcher, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000427-e000427
Open Access | Times Cited: 15
Showing 15 citing articles:
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
Massimo Franchini, Daniele Focosi, Mario Cruciani, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 41-41
Open Access | Times Cited: 8
Massimo Franchini, Daniele Focosi, Mario Cruciani, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 41-41
Open Access | Times Cited: 8
Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: A retrospective cohort study
Remigius Gröning, J Walde, Clas Ahlm, et al.
International Journal of Infectious Diseases (2024) Vol. 144, pp. 107046-107046
Open Access | Times Cited: 7
Remigius Gröning, J Walde, Clas Ahlm, et al.
International Journal of Infectious Diseases (2024) Vol. 144, pp. 107046-107046
Open Access | Times Cited: 7
Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis
Massimo Franchini, Mario Cruciani, Carlo Mengoli, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1514-1522
Closed Access | Times Cited: 7
Massimo Franchini, Mario Cruciani, Carlo Mengoli, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1514-1522
Closed Access | Times Cited: 7
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Convalescent plasma transfusion for immunocompromised viremic patients with COVID‐19: A retrospective multicenter study
Marjolaine Destremau, H. Chaussade, Victor Hemar, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access | Times Cited: 1
Marjolaine Destremau, H. Chaussade, Victor Hemar, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access | Times Cited: 1
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review
Alain Amstutz, Christof Schönenberger, Benjamin Speich, et al.
Journal of Clinical Epidemiology (2024) Vol. 174, pp. 111469-111469
Closed Access | Times Cited: 1
Alain Amstutz, Christof Schönenberger, Benjamin Speich, et al.
Journal of Clinical Epidemiology (2024) Vol. 174, pp. 111469-111469
Closed Access | Times Cited: 1
An overview of the development of pharmacotherapeutics targeting SARS-CoV-2
Tom Lucaj, Ian Hay, Amirreza Samarbakhsh, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104126-104126
Closed Access | Times Cited: 1
Tom Lucaj, Ian Hay, Amirreza Samarbakhsh, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104126-104126
Closed Access | Times Cited: 1
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
Kanal Singh, Joseph M. Rocco, Véronique Nussenblatt
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 321-332
Closed Access | Times Cited: 1
Kanal Singh, Joseph M. Rocco, Véronique Nussenblatt
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 321-332
Closed Access | Times Cited: 1
Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2–Infected Hamsters
Timothy D. Carroll, Talia S. Wong, Mary Kate Morris, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 6, pp. 1702-1710
Open Access | Times Cited: 4
Timothy D. Carroll, Talia S. Wong, Mary Kate Morris, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 6, pp. 1702-1710
Open Access | Times Cited: 4
Hyperimmune Plasma and Immunoglobulins Against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 3
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 3
The Importance of Natural and Acquired Immunity to SARS-CoV-2 Infection in Patients on Peritoneal Dialysis
Marko Baralić, Mirjana Laušević, Danica Ćujić, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 135-135
Open Access
Marko Baralić, Mirjana Laušević, Danica Ćujić, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 135-135
Open Access
COVID-19 in the immunocompromised host
Eric D. Morrell, F. Linzee Mabrey, J Goodman, et al.
European Respiratory Society eBooks (2024)
Closed Access
Eric D. Morrell, F. Linzee Mabrey, J Goodman, et al.
European Respiratory Society eBooks (2024)
Closed Access
Exploring passive immunization therapies for COVID ‐19 management in rheumatic patients
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 9
Closed Access
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 9
Closed Access
Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: a multicenter French study
A.P. Chaudhry, Floriane Gallais, Pierre‐Emmanuel Falcoz, et al.
Respiratory Medicine and Research (2024) Vol. 87, pp. 101145-101145
Open Access
A.P. Chaudhry, Floriane Gallais, Pierre‐Emmanuel Falcoz, et al.
Respiratory Medicine and Research (2024) Vol. 87, pp. 101145-101145
Open Access
